Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
206.08
-2.17 (-1.04%)
Nov 18, 2025, 1:27 PM EST - Market open
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $5.98 billion as of November 18, 2025. Its market cap has increased by 20.56% in one year.
Market Cap
5.98B
Enterprise Value
5.18B
1-Year Change
20.56%
Ranking
Category
Stock Price
$206.08
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $5.98B, an increase of 6,367.33%. That is a compound annual growth rate of 66.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 6.04B | 34.03% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |